AstraZeneca's hopes for baxdrostat are high, as in early 2023 it acquired the drug by purchasing its developer -- biotech ...

(Alliance News) - AstraZeneca PLC on Sunday announced results from the phase 3 trial of its Baxdrostat treatment which showed a statistically significant reduction in the systolic blood pressure of ...

Black adults living in communities with few grocery stores who participated in a grocery support program providing ...

People in their 30s may risk a heart attack or stroke in later life even when they have "normal" blood pressure, if it's too high or steeply rising, according to a new study led by UCL researchers.

Low blood pressure, or hypotension, can be dangerous as it impairs oxygen delivery to vital organs. When mean arterial ...

Hypertension - a condition where blood pressure is consistently higher than normal - is poorly managed in South Africa. Remarkable findings from a study in rural KwaZulu-Natal suggest a compelling ...

A new aldosterone synthase inhibitor added to SGLT2 inhibitors reduces uncontrolled blood pressure in patients with chronic kidney disease, according to the results of a phase 2 trial.

People in their thirties may be at an increased risk of heart attack or stroke even if they have 'normal' blood pressure, new ...

A new blood pressure calculator built on extensive clinical trial data helps doctors accurately estimate how much each ...

A record-breaking 4,432 scientific abstracts accepted at the American Heart Association’s meeting here adorned posters, ...

People in their thirties may risk a heart attack or stroke in later life even when they have ‘normal’ blood pressure, if it’s too high or steeply rising ...

Managing hypertension may lower dementia risk A new 2025 high blood pressure guideline from the American Heart Association (AHA) and the American College of Cardiology (ACC) calls for earlier ...